ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

HCM Hutchmed (china) Limited

267.50
3.00 (1.13%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hutchmed (china) Limited LSE:HCM London Ordinary Share KYG4672N1198 ORD USD0.10
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  3.00 1.13% 267.50 265.00 267.00 273.00 265.50 266.50 18,840 16:35:28
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 838M 100.78M - N/A 0
Hutchmed (china) Limited is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker HCM. The last closing price for Hutchmed (china) was 264.50p. Over the last year, Hutchmed (china) shares have traded in a share price range of 173.60p to 338.00p.

Hutchmed (china) currently has 871,256,270 shares in issue.

Hutchmed (china) Share Discussion Threads

Showing 801 to 824 of 4100 messages
Chat Pages: Latest  44  43  42  41  40  39  38  37  36  35  34  33  Older
DateSubjectAuthorDiscuss
17/3/2016
21:12
Can anyone say why we actually needed the ipo?

Presumably Hcm doesn't need the cash?

Feel slightly aggrieved that a) my holding has plummeted in value (although I'm more likely to,buy more than sell) and b) we're now exposed to the US mkt and tribulations of fx arbitrage.

cisk
17/3/2016
17:25
It's a quality company with huge prospects but I can't understand the logic of the ADS price. Sold my last tranche this morning (luckily) as I think the whole US market is going to tank which will drag good and bad down with it. The QE experiment is quickly unfolding so have been topping up my gold!!
essential
17/3/2016
16:36
We got shafted.
nhb001
17/3/2016
16:01
Maybe but the stock is in very choppy sector waters in an uncertain market.Moreover the sizeable placing discount does nothing to dismiss suggestions that the biotech sector might weaken further before things get better.
steeplejack
17/3/2016
15:44
makes me wonder why the IPO has taken so long when originally filed 5 months ago

I wonder if they've been delaying it due to market conditions and the discount and finally gave in.

Not good but I do not think it will stay at this market cap for very long, there's far too much upside and news to come this year

nerdofsteel
17/3/2016
15:17
For sure,so it's a bit of a mystery why the AIM quote held up so well,this morning.I'm surprised that the company proceeded with the issue at this time.Ordinarily,you'd expect a discount of perhaps 3% -5% to the benchmark AIM quote but the bankers obviously advised the company to entertain a discount of over 15% which makes you wonder,why the hell they went ahead.Perhaps the bankers felt,in the context of the massive price appreciation of recent years,they may as well bite the bullet.Look at the pummelling biotech trusts have suffered this year and today for that matter.Without doubt,the pricing level of the ADRs leaked out and it explains why the price plummeted a month or so back.Maybe they tried to finesse things for a few weeks and let things quieten down.Hasn't done much good.
steeplejack
17/3/2016
15:01
It was always going to be arbitraged. They offered a 15% discount.
nhb001
17/3/2016
14:39
Just the biotech sector is well out of favour helped by sound bites in US election year.Unless the company comes out with good news pronto,looks like the stock will equalise around the placing price.The US institutions drove a hard bargain when it came to pricing the offer and if the other bulletin boards are anything to go by,it's caught the punters out.Of course,the placing is quite sizeable in increasing the free equity outside of the Hutchinson interest.
steeplejack
17/3/2016
14:31
maybe we should change our name - clearly the word China puts off many U.S. Investors
nerdofsteel
17/3/2016
10:32
The price reaction today suggests you might be right.They're holding up well.
steeplejack
17/3/2016
07:34
I think that explains the sharp drop in share price some weeks back.The intended pricing of the ADSs must of leaked out.An equivalent London price of £19.42 is a sizeable discount to the existing AIM price.I'd be surprised if we didn't see a few taking a quick profit in the US.Maybe,it was optimistic but I thought (especially given you can get a slug of stock)they might get this placing away at nearer the AIM price ie £22-50 odd.Not to be.I can see them doing the greenshoe,additional placing,in full.Who the hell wouldn't want to go for that at a discount to the London price of getting on for 15%!Nonetheless,they've done the issue in a difficult environment and have a listing in the US which will no doubt prove to be the primary vehicle for any intended fund raising in future years (as it has proven for GWP).

"7,500,000 ADSs were sold in the Offering at a price of US$13.50 per ADS, and the offering price is thus equivalent to approximately GBP19.42 per ordinary share (on the basis of an assumed exchange rate as quoted in the preliminary prospectus of GBP1.00 to US$1.39). Each ADS represents one-half of one ordinary share of Chi-Med. The ADSs have been approved for listing on the Nasdaq Global Select Market and are expected to begin trading on March 17, 2016 under the ticker symbol "HCM." Chi-Med's ordinary shares will continue to be traded on the AIM market of the London Stock Exchange following the Offering under the ticker symbol "HCM."

steeplejack
16/3/2016
11:11
Big day tomorrow, massive fundraise that is not dilutive and will help us to push several drug candidates over the line. Moving ever closer towards revenues measured in billions rather than millions
nerdofsteel
16/3/2016
10:40
Bit of buying today ahead of listing in us
aim999
15/3/2016
11:23
Over $100m in the bank on Thursday, followed quickly by major pipeline news I suspect
nerdofsteel
10/3/2016
21:27
Its a great sign of the appetite for our company in the US. Exciting times!
twonky
10/3/2016
18:45
I don't think so.I think the size of the greenshoe as its called,a reserve allotment,has to be agreed in advance.Anyway,from our point of view,better to leave US investors hungry!
steeplejack
10/3/2016
16:46
Can they sell more then the 15%?
twonky
10/3/2016
15:37
3/8/2016 9:30:18 AM

Hutchison China MediTech (Chi-Med), a company developing novel drugs for oncology and autoimmune diseases, is scheduled to raise $100 million by listing ADS shares on the NASDAQ exchange. The offering values Chi-Med at almost $1 billion. Each ADS will be equal to one-half of each London-traded Chi-Med share. Chi-Med will issue 6.1 million ADSs at a price to be determined by demand, though it will probably be close to one-half the present London ADS value, or $16.33 each. The underwriters have the option of placing another $15 million of stock to cover overallotments. The transaction is scheduled to take place the week of March 14th.

Yes,it looks like it's been oversubscribed.Hopefully ,by substantially more than the $15m greenshoe.

steeplejack
10/3/2016
12:17
I guess it's all about the price. Any sign what the IPO shares will be priced at. Do they have to proceed at the same as the AIM converted or can they be priced less to lure people in?
nhb001
10/3/2016
11:51
Looks as if the IPO is over-subscribed

hxxp://www.globalcorporateventuring.com/article.php/13424/chi-med-aims-for-115m-in-us-ipo

nerdofsteel
08/3/2016
13:51
The NASDAQ IPO website has been updated in the last few minutes with an expected IPO date of the 17th March
nerdofsteel
08/3/2016
13:48
Looking at the Beigene timetable, looks very much like we are in the final stages now, and for the first time, we now appear on the NASDAQ Upcoming IPO page

Now the ADR's are priced it is a matter of a few days

nerdofsteel
08/3/2016
12:45
It's from this site , presumably , although a few other US ipo sites have the same data. I doubt very much it will be next week , but I'll be happy to be proved wrong.

hxxp://www.renaissancecapital.com/health-care/hutchison-china-meditech/ipo-hcm.html

miti 1000
08/3/2016
08:14
Hi Nerdofsteel - I wasn't aware that the IPO was scheduled for next week - can I ask where you have seen this info
jatin724
Chat Pages: Latest  44  43  42  41  40  39  38  37  36  35  34  33  Older

Your Recent History

Delayed Upgrade Clock